Medical cannabis utilization in children - a study based on a nationwide cohort.

ABSTRACT:

Introduction

This study aimed to evaluate the utilization of medical cannabis in a pediatric population and compare short-term persistence rates with those in adolescents and young adults.

Methods

In this retrospective, nationwide cohort study supplemented by data from an open-label study of children with ASD, patient cases under 12 years of age who received medical cannabis treatment between 2018 and 2022 were analyzed. The primary outcome assessed was treatment persistence within the first 3 months. Secondary outcomes included changes in THC ratios, amounts dispensed, and reasons for treatment discontinuation.

Results

The patient population consisted of 1,341 children using medical cannabis for ASD (751), epilepsy (330), Tourette syndrome (165), and pediatric cancer

SUBMITTER: Treves N 

PROVIDER: S-EPMC12678362 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature